AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
ESCC, |
TE1 |
|
|
|
- |
vitro+vivo, |
ESCC, |
KYSE-510 |
|
|
|
- |
in-vitro, |
Nor, |
Het-1A |
|
|
|
TumCP↓, LC3‑Ⅱ/LC3‑Ⅰ↑, p62↓, p‑AMPK↑, mTOR↓, TumAuto↑, NCOA4↑, MDA↑, Iron↑, TumW↓, TumVol↓, ATG5↑, ATG7↑, TfR1/CD71↓, FTH1↓, ROS↑, Iron↑, Ferroptosis↑, *toxicity↓,
*ROS↓, *PKM2↓, *Hif1a↓, *TGF-β↓, *AMPK↑, *Inflam↓, *PI3K↓, *Akt↑, *NRF2↑, *NF-kB↓,
*α-SMA↓, *TGF-β1↓, *IL10↑, *p‑AMPK↑, *p‑mTOR↓, *P70S6K↓, *cardioP↑,
Inflam↓, IL6↓, MCP1↓, COX2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, eff↑, EGFR↓, Glycolysis↓, Dose?, p27↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2↓, ChemoSen↑, eff↑, eff↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
LDL↓, AMPK↑, ACLY↓,
| - |
in-vitro, |
Nor, |
HUVECs |
|
|
|
- |
in-vitro, |
Nor, |
MEF |
|
|
|
*Glycolysis↑, *GlucoseCon↑, *Apoptosis↓, *UCP1↓, *AMPK↑, GLUT1↑, mt-ROS↑,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*Pain↓, *TRPV1↑, AMPK↑, ROS↑, TumCP↑, Apoptosis↑, TumCCA↑, Casp3↑, BAX↑, Bak↑, cl‑PARP↑, Bcl-2↓, RNS↑, *glucose↓, *Insulin↑, *BP↓, *AntiAg↑, ER Stress↑, Hif1a↓, chemoPv↑,
*AntiCan↑, *Inflam↓, *antiOx↑, *TRPV1↑, *AMPK↑, *SIRT1↑, *NADPH↓, *ROS↓, *MAPK↓, *eNOS↑, *Wnt/(β-catenin)↓, RenoP↑,
Warburg↓, *PKM2↓, *COX2↓, *Inflam↓, *Sepsis↓, *AMPK↑, *PKA↑, *mitResp↑, *FAO↑, *FASN↓, *PGM1?, *ATP↑, *ROS↓,
*CRM↓, *Dose?, *AntiAge↑, *Acetyl-CoA↓, *SIRT1↑, *AMPK↑, *mTORC1↓, *AntiAge↑, chemoP↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*GutMicro↑, *neuroP↑, *eff↑, *Dose↝, *AMPK↑, *SIRT1↑, *mTOR↓, *NRF2↑, *p‑tau↓,
| - |
in-vitro, |
BC, |
BT474 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
Hif1a↓, GLUT1↓, LDH↓, GlucoseCon↓, lactateProd↓, ATP↓, p‑AMPK↑, ECAR↓, OCR↓, *toxicity↓,
*glucose↓, ROS↑, LC3B↑, p62↓, p‑mTOR↓, p‑AMPK↑,
| - |
in-vitro, |
Nor, |
MRC-5 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
mTOR↓, AMPK↑, selectivity↑, ROS↑, selectivity↑, HO-1↓, *NRF2↑, NRF2↓, *HO-1↑,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
- |
in-vitro, |
Nor, |
hTERT-HPNE |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AMPK↑, mTOR↑, UPR↑, ER Stress↑, selectivity↑, TumCP↓, PERK↑, ATF4↑, ATF6↑,
| - |
in-vitro, |
PC, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
- |
in-vivo, |
PC, |
NA |
|
|
|
tumCV↓, *toxicity∅, TumCMig↓, TumCI↓, Apoptosis↑, AMPK↑, lipoGen↓, ACC↓, FASN↓,
*hepatoP↑, *AMPK↑, *SIRT1↑, *ROS↓, STAT3↓, TNF-α↓, NF-kB↓, *IL2↓, *IFN-γ↓, *GSH↑, *SREBP1↓, *ZO-1↑, *TLR4↓, BAX↑, Bcl-2↓, XIAP↓, Fas↑, Casp8↑, Beclin-1↑, *TXNIP↓, *Casp1↓, *IL1β↓, *IL18↓, *NLRP3↓, *MDA↓, *SOD↑, *NRF2↑, *ER Stress↓, *ALAT↓, *AST↓, *iNOS↓, *IL6↓, *HO-1↑, *NQO1↑, *PPARα↑, *ATF4↓, *CHOP↓, *Inflam↓, *antiOx↑, *GutMicro↑,
*AMPK↑, *mTOR↓, *NLRP3↓, *Pyro↓,
*AntiDiabetic↑, *AntiAge↑, *toxicity⇅, *CRM↑, *Strength↑, *LDL↓, *AMPK↑, *TAC↑, *ROS↓, *Inflam↓, Risk↓, *cardioP↑, *ALAT↓, *NRF2↑, *SOD2↑, *TrxR1↑, *NQO1↑, *NQO2↑,
*glucose↓, *glucoNG↓, *AMPK↑,
*AntiAge↑, *AMPK↑, *mPGES-1↓, *Ca+2↑, *ER Stress↑, *OS↑, *ROS↓,
*AntiAge↑, *IGF-1↓, *AMPK↑, *CRM↑, *PGC-1α↑, *mtDam↓, *motorD↑, *hepatoP↑, *Dose↝,
*AMPK↑, *SIRT1↑, *PGC-1α↑, *BP↓, *CRM↑, *Dose↝, *mtDam↓, *ALAT↓, *hepatoP↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
*antiOx↑, *ROS↓, *cognitive↑, *neuroP↑, *SIRT1↑, *AMPK↑, *GPx↑, *HO-1↑, *GSK‐3β↑, *COX2↓, *PGE2↓, *NF-kB↓, *NO↓, *Casp3↓, *MMP3↓, *MMP9↓, *MMP↑, *GSH↑, *other↑, *BioAv↑, *memory↑, *GlutMet↑, *BioAv↓, *Half-Life↓, *toxicity∅,
*AMPK↑, *P21↑, *Dose↓, *chemoPv↑,
*antiOx↑, *Inflam↓, *ROS↓, *NF-kB↓, *AMPK↑, *SIRT1↑, *miR-155↓, *NLRP3↓,
*NLRP3↓, *ASC↓, *Casp1↓, *IL1β↓, *ALAT↓, *AST↓, *AMPK↑, *mTOR↓, *P70S6K↓,
*Dose↝, *Apoptosis↓, *Casp3↓, *Bcl-2↑, *Inflam↓, *VCAM-1↓, *ICAM-1↓, *E-sel↓, *ROS↓, *SOD↑, *AMPK↑, *NRF2↑, *HO-1↑, *TNF-α↓, *IL1β↓, *IL6↓,
| - |
in-vivo, |
AD, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
PC12 |
|
|
|
*cognitive↑, *p‑PI3K↓, *p‑Akt↓, *AMPK↑, *VDAC1↓, *neuroP↑, *PARK2↑, *PTEN↑, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p62↓, *Aβ↓, *Apoptosis↓,
Showing Research Papers: 1 to 30 of 30
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 30
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, HO-1↓, 1, Iron↑, 2, MDA↑, 1, NRF2↓, 1, PARK2↑, 1, RNS↑, 1, ROS↑, 6, mt-ROS↑, 1,
Metal & Cofactor Biology ⓘ
FTH1↓, 1, NCOA4↑, 1, TfR1/CD71↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 2, MEK↓, 1, MMP↓, 2, OCR↓, 1, PINK1↑, 1, Raf↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
ACC↓, 1, ACLY↓, 1, AMPK↑, 7, p‑AMPK↑, 3, ATG7↑, 1, ECAR↓, 1, FASN↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, LDH↓, 1, LDL↓, 1, lipoGen↓, 1, p‑S6K↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, Bak↑, 1, BAX↑, 3, Bax:Bcl2↑, 1, Bcl-2↓, 4, Bcl-xL↓, 1, Casp3↑, 2, cl‑Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, Fas↑, 1, Ferroptosis↑, 1, p27↑, 1, Telomerase↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
ATF6↑, 1, ER Stress↑, 2, PERK↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, Beclin-1↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, LC3B↑, 1, LC3II↑, 1, p62↓, 3, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1, cl‑PARP↑, 2,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, CD133↓, 1, CSCs↓, 1, Diff↓, 1, EMT↓, 1, ERK↓, 1, HDAC↓, 1, mTOR↓, 2, mTOR↑, 2, p‑mTOR↓, 1, p‑mTORC1↓, 1, n-MYC↓, 1, Nestin↓, 1, NOTCH↓, 1, PI3K↓, 1, PTEN↑, 1, SOX2↓, 1, STAT3↓, 2, TumCG↓, 1,
Migration ⓘ
E-cadherin↑, 1, miR-139-5p↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, Snail↓, 1, TumCI?, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 2, TumCP↑, 1, TumMeta↓, 1, uPA↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
ATF4↑, 1, EGFR↓, 1, Hif1a↓, 3, VEGF↓, 1, VEGFR2↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, GLUT1↑, 1,
Immune & Inflammatory Signaling ⓘ
CCR7↓, 1, COX2↓, 1, CXCR4↓, 1, IL6↓, 1, Inflam↓, 1, JAK2↓, 1, MCP1↓, 1, NF-kB↓, 1, PGE2↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose?, 1, Dose↓, 1, Dose↑, 1, eff↓, 1, eff↑, 3, eff↝, 1, RadioS↑, 1, selectivity↑, 4,
Clinical Biomarkers ⓘ
EGFR↓, 1, IL6↓, 1, LDH↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, chemoP↑, 1, chemoPv↑, 1, RenoP↑, 1, Risk↓, 1, TumVol↓, 1, TumW↓, 1,
Total Targets: 137
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 4, GPx↑, 1, GSH↑, 2, HO-1↑, 4, MDA↓, 1, NQO1↑, 2, NRF2↑, 6, PARK2↑, 1, ROS↓, 9, SOD↑, 2, SOD2↑, 1, TAC↑, 1, TrxR1↑, 1, VDAC1↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, Insulin↑, 1, mitResp↑, 1, MMP↑, 1, mtDam↓, 2, PGC-1α↑, 2, UCP1↓, 1,
Core Metabolism/Glycolysis ⓘ
Acetyl-CoA↓, 1, ALAT↓, 4, AMPK↑, 19, p‑AMPK↑, 1, CRM↓, 1, CRM↑, 3, FAO↑, 1, FASN↓, 1, glucoNG↓, 1, glucose↓, 3, GlucoseCon↑, 1, GlutMet↑, 1, Glycolysis↑, 1, LDL↓, 1, NADPH↓, 1, PGM1?, 1, PKM2↓, 2, PPARα↑, 1, SIRT1↑, 7, SREBP1↓, 1,
Cell Death ⓘ
Akt↑, 1, p‑Akt↓, 1, Apoptosis↓, 3, Bcl-2↑, 1, Casp1↓, 2, Casp3↓, 2, iNOS↓, 1, MAPK↓, 1, Pyro↓, 1, TRPV1↑, 2,
Transcription & Epigenetics ⓘ
other↑, 1,
Protein Folding & ER Stress ⓘ
CHOP↓, 1, ER Stress↓, 1, ER Stress↑, 1, NQO2↑, 1,
Autophagy & Lysosomes ⓘ
LC3‑Ⅱ/LC3‑Ⅰ↑, 1, p62↓, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↑, 1, IGF-1↓, 1, mTOR↓, 3, p‑mTOR↓, 1, mTORC1↓, 1, P70S6K↓, 2, PI3K↓, 1, p‑PI3K↓, 1, PTEN↑, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
AntiAg↑, 1, Ca+2↑, 1, E-sel↓, 1, miR-155↓, 1, MMP3↓, 1, MMP9↓, 1, PKA↑, 1, TGF-β↓, 1, TGF-β1↓, 1, TXNIP↓, 1, VCAM-1↓, 1, ZO-1↑, 1, α-SMA↓, 1,
Angiogenesis & Vasculature ⓘ
ATF4↓, 1, eNOS↑, 1, Hif1a↓, 1, NO↓, 1,
Immune & Inflammatory Signaling ⓘ
ASC↓, 1, COX2↓, 2, ICAM-1↓, 1, IFN-γ↓, 1, IL10↑, 1, IL18↓, 1, IL1β↓, 3, IL2↓, 1, IL6↓, 2, Inflam↓, 7, mPGES-1↓, 1, NF-kB↓, 3, PGE2↓, 1, TLR4↓, 1, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
p‑tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1, NLRP3↓, 4,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, Dose?, 1, Dose↓, 1, Dose↝, 4, eff↑, 1, Half-Life↓, 1,
Clinical Biomarkers ⓘ
ALAT↓, 4, AST↓, 2, BP↓, 2, GutMicro↑, 2, IL6↓, 2,
Functional Outcomes ⓘ
AntiAge↑, 5, AntiCan↑, 1, AntiDiabetic↑, 1, cardioP↑, 2, chemoPv↑, 1, cognitive↑, 2, hepatoP↑, 3, memory↑, 1, motorD↑, 1, neuroP↑, 3, OS↑, 1, Pain↓, 1, Strength↑, 1, toxicity↓, 2, toxicity⇅, 1, toxicity∅, 2,
Infection & Microbiome ⓘ
Sepsis↓, 1,
Total Targets: 133
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:9 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page